Find uplifting stories about heroes, innovations, and solutions
240 results for "ticks"
A simple trail trick could make walks in the woods safer for everyone. University of Ottawa researchers discovered that spreading woodchips on forest paths cuts tick populations dramatically.
Scientists at the University of Georgia are making progress on understanding alpha-gal syndrome, a mysterious tick-triggered meat allergy affecting up to 450,000 Americans. Their research could lead to treatments for people who currently face life-altering dietary restrictions.
A groundbreaking study of 3,000 patients shows a blood transfusion method slashes death rates from severe babesiosis by nearly three-quarters. The findings offer hope for those battling the tick-borne illness spreading with climate change.
Arizona State University researchers just cracked a mystery that could lead to new treatments for tularemia, a deadly tick-borne disease so potent that just 10 bacterial cells can cause infection. For the first time, scientists isolated and studied the proteins that help this dangerous pathogen survive inside human cells.
As ticks spread to new regions across America, researchers are racing toward a breakthrough that could protect us from all tick-borne illnesses at once. A new Lyme vaccine shows 70% effectiveness, and scientists are now working on something even better.
Scientists at Monash University discovered a tick protein that blocks immune signals linked to multiple sclerosis, rheumatoid arthritis, and cancer. This natural protein could lead to more effective treatments for diseases that currently have limited options.
Scientists at Monash University discovered a tick protein that blocks two types of immune signals at once, a breakthrough that could lead to more effective treatments for rheumatoid arthritis, multiple sclerosis, and other inflammatory diseases. This natural protein works differently than anything found before.
A University of Kentucky scientist is turning Lyme disease bacteria against itself in a promising new treatment approach. The breakthrough comes as tick-borne illnesses have jumped 128% nationwide since 2020.
After more than 20 years without a Lyme disease vaccine in the U.S., Pfizer's new four-dose vaccine shows promising results that could protect millions from the most common tick-borne illness in America. The vaccine, tested across thousands of people in the U.S., Canada, and Europe, marks a hopeful step forward for outdoor enthusiasts and those living in high-risk areas.
A new vaccine could soon protect people from Lyme disease for the first time in over 20 years. Pfizer and Valneva's candidate showed over 70% effectiveness in preventing the tick-borne illness that affects hundreds of thousands annually.
A new Lyme disease vaccine from Pfizer has shown 70% effectiveness in clinical trials, offering hope for protection against the tick-borne illness that affects hundreds of thousands annually. This marks the first promising Lyme vaccine in over two decades.
A pharmaceutical company has achieved a 100% cure rate for a dangerous tick-borne disease in patients whose immune systems couldn't fight it off. The breakthrough could reshape treatment guidelines for babesiosis, a debilitating illness that often strikes alongside Lyme disease.
A small clinical trial achieved a perfect cure rate for a stubborn tick-borne illness that can last for years in people with weakened immune systems. The breakthrough offers hope for thousands of Americans suffering from chronic babesiosis.
A promising new Lyme disease vaccine from Pfizer and Valneva could protect against nearly half a million annual U.S. infections. The shot targets bacteria inside ticks before they can infect people.
An island where 15% of residents have contracted Lyme disease is trying something unprecedented: specially bred mice that can't spread the bacteria to ticks. MIT researchers believe these tiny helpers could break the disease cycle that's plagued Nantucket for decades.
The federal government just announced one of the most ambitious campaigns ever to fight Lyme disease, which affects nearly half a million Americans every year. New tick control programs, AI-powered diagnostics, and $2.5 million in innovation prizes aim to turn the tide on this growing health threat.
A groundbreaking Lyme disease vaccine has proven 73% effective in major trials, bringing hope to millions at risk from tick-borne illness. After decades without protection, regulatory approval could arrive soon for people ages five and up.
A newly approved topical solution gives U.S. cattle producers their first effective tool to prevent and treat New World screwworm infestations that threaten the agricultural industry. The pour-on treatment also controls cattle fever tick, offering ranchers multiple protections in one application.
A British watchmaker is sending a timepiece to the moon's surface aboard a lunar rover later this year, beating major Swiss brands to the lunar comeback. The mission will test both cutting-edge robotics and whether a mechanical watch can tick on the moon.
Riverside County's job market shows signs of improvement as the unemployment rate ticked down to 5.4% in February, offering hope to workers across the region. While some industries shed jobs, construction, hospitality, and professional services added 1,500 new positions.
Showing 20 of 240